MedSign, a Bengaluru based health-tech startup working in the field of Digitalization of Health Records and Continuity of Care, has announced that it has raised an undisclosed amount as a Seed Fund from SMSRC, a leading strategic advisor and research catering to the pharma industry in India and Bangladesh, as a part of its strategic collaboration.

MedSign was founded in 2018 by healthcare professionals Dr. Kamlesh Patel, Shrihari Shidhaye and VivanDarole. The MedSign platform aims to improve patient outcomes by addressing two missing pieces of the healthcare ecosystem i.e. improving accessibility of real-time, comprehensive, transferrable and transparent patients health records at the point-of-care & improving Continuity of Care.

Speaking on this investment, Shrihari Shidhaye, Founder-Director of MedSign, said, “As we embark on our next level of growth, this Seed Funding from SMSRC will help us strengthen our offerings to the market and thereby enhance patient care by digitizing patient’s health journey to create a comprehensive digital medical database, that is secure, easily accessible and real-time for clinicians & patients. Further, SMSRC’s widespread existing doctor network and relationships across the healthcare ecosystem will be an important avenue towards rapid penetration of MedSign. We also plan to raise additional funds to fuel our growth and expansion plans.”

The MedSign platform offers three product suites, MedSign Pro, MedSign Care and MedSign Connect. “MedSign Pro” is a cutting edge, comprehensive yet simple EMR based clinic management software / application; “MedSign Care” is an interface for patients, enabling them to upload, view and share  health records, book appointment for in-clinic or tele-consultations and track health parameters on a regular basis; and “MedSign Connect” truly democratises the patient health records and makes it easily available for clinicians real-time at the point of care, securely, enabling a multi-disciplinary treatment approach.